Gemcitabine | Teva Parenteral Medicines, Inc. Breastfeeding
Breast milk is superior in nutrition, It provides resistance against infections and allergies, It is naturally sterile. Despite all the advantages of breastfeeding some mothers choose to pause the breastfeeding in fear of harmful effects of medicines passing in breast milk. Are you wondering about breastfeeding and using Gemcitabine | Teva Parenteral Medicines, Inc. ? Know what is Gemcitabine | Teva Parenteral Medicines, Inc. and how it can affect your breast milk and whether Gemcitabine | Teva Parenteral Medicines, Inc. is safe for your kid or not.

What is Gemcitabine | Teva Parenteral Medicines, Inc. used for?


Gemcitabine for Injection, USP is a nucleoside metabolic inhibitor indicated: •in combination with carboplatin, for the treatment of advanced ovarian cancer that has relapsed at least 6 months after completion of platinum-based therapy (1.1) •in combination with paclitaxel, for first-line treatment of metastatic breast cancer after failure of prior anthracycline-containing adjuvant chemotherapy, unless anthracyclines were clinically contraindicated (1.2) •in combination with cisplatin for the treatment of non-small cell lung cancer (1.3) •as a single agent for the treatment of pancreatic cancer (1.4) 1.1Ovarian Cancer Gemcitabine for Injection, USP in combination with carboplatin is indicated for the treatment of patients with advanced ovarian cancer that has relapsed at least 6 months after completion of platinum-based therapy. 1.2Breast Cancer Gemcitabine for Injection, USP in combination with paclitaxel is indicated for the first-line treatment of patients with metastatic breast cancer after failure of prior anthracycline-containing adjuvant chemotherapy, unless anthracyclines were clinically contraindicated. 1.3Non-Small Cell Lung Cancer Gemcitabine for Injection, USP is indicated in combination with cisplatin for the first-line treatment of patients with inoperable, locally advanced (Stage IIIA or IIIB), or metastatic (Stage IV) non-small cell lung cancer. 1.4Pancreatic Cancer Gemcitabine for Injection, USP is indicated as first-line treatment for patients with locally advanced (nonresectable Stage II or Stage III) or metastatic (Stage IV) adenocarcinoma of the pancreas. Gemcitabine for Injection, USP is indicated for patients previously treated with 5-FU.

I am currently breastfeeding and I want to know if using Gemcitabine | Teva Parenteral Medicines, Inc. is safe for my kid? Does it have any effect on milk production?

Gemcitabine | Teva Parenteral Medicines, Inc. dangerous while breastfeeding
Our analysis of Gemcitabine which are active ingredients in Gemcitabine | Teva Parenteral Medicines, Inc. indicates that Gemcitabine | Teva Parenteral Medicines, Inc. is dangerous to use in breastfeeding. We strongly recommend you to go through detailed analysis of Gemcitabine as below and do not use Gemcitabine | Teva Parenteral Medicines, Inc. during breastfeeding.

Statement of Manufacturer/Labeler about breastfeeding usage
8.3Nursing Mothers It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants from gemcitabine, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.

Gemcitabine | Teva Parenteral Medicines, Inc. Breastfeeding Analsys


Gemcitabine while Breastfeeding

Dangerous

CAS Number: 95058-81-4

Drug is cleared from the body in 16 elimination half-lives. Resuming breastfeeding is likely safe after 7 days of of pumping-and-dumping.


Gemcitabine | Teva Parenteral Medicines, Inc. Breastfeeding Analsys - 2


Gemcitabine while Breastfeeding

CAS Number: 95058-81-4

Most sources consider breastfeeding to be contraindicated during maternal antineoplastic drug therapy. It might be possible to breastfeed safely during intermittent gemcitabine therapy with an appropriate period of breastfeeding abstinence; the manufacturer recommends an abstinence period of 1 week after the last dose. Chemotherapy may adversely affect the normal microbiome and chemical makeup of breastmilk.[1] Women who receive chemotherapy during pregnancy are more likely to have difficulty nursing their infant.[2]


Gemcitabine | Teva Parenteral Medicines, Inc. and breastfeeding

What if I already have used Gemcitabine | Teva Parenteral Medicines, Inc.?

You should immediately inform your health care provider about Gemcitabine | Teva Parenteral Medicines, Inc. usage and your breastfeeding interval after usage of . If you feel baby is having abnormal behavior or any other health issue please call 911 immediately or contact nearest medical emergency center.


My health care provider has asked me to use Gemcitabine | Teva Parenteral Medicines, Inc., what to do?

Please double check with your doctor if he is aware of your breastfeeding stratus, Ask your doctor if there is any safe alternative of Gemcitabine | Teva Parenteral Medicines, Inc.. Check with your doctor if you shall temporally stop breastfeeding. You may go for second opinion as well. Still after all of this if your doctor still recommends Gemcitabine | Teva Parenteral Medicines, Inc. then go for it as they have access on more detailed medical and scientific information and they understand your individual medical situation much better.


If I am using Gemcitabine | Teva Parenteral Medicines, Inc., will my baby need extra monitoring?

Extreme level of monitoring required as Gemcitabine | Teva Parenteral Medicines, Inc. could be dangerous for kid.


Who can I talk to if I have questions about usage of Gemcitabine | Teva Parenteral Medicines, Inc. in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week